Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NvfiledCriticalJanssen Pharmaceutica Nv
Publication of TW200744582ApublicationCriticalpatent/TW200744582A/en
Application grantedgrantedCritical
Publication of TWI435722BpublicationCriticalpatent/TWI435722B/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The present invention relates to a use of one or more novel benzo-fused heterocycle sulfamide derivatives of formula (I) and formula (II) as herein defined for the manufacture of a medicament for neuroprotection, for treating an acute neurodegenerative disorder, for treating a chronic neurodegenerative disorder and / or for preventing neuron death or damage following brain, head and / or spinal cord trauma or injury.
TW95147364A2005-12-192006-12-18Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents
TWI435722B
(en)
Heterocyclocarbonylaminothiazoles, cosmetic or dermatological preparations containing said heterocyclocarbonylaminothiazoles, and use thereof to combat or prevent undesired pigmentation of the skin.